ZIC1

Chr 3AD

Zic family zinc finger 1

Also known as: BAIDCS, CRS6, ZIC, ZNF201

This gene encodes a member of the ZIC family of C2H2-type zinc finger proteins. Members of this family are important during development. Aberrant expression of this gene is seen in medulloblastoma, a childhood brain tumor. This gene is closely linked to the gene encoding zinc finger protein of the cerebellum 4, a related family member on chromosome 3. This gene encodes a transcription factor that can bind and transactivate the apolipoprotein E gene. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
GOFmechanismADLOEUF 0.362 OMIM phenotypes
Clinical SummaryZIC1
🧬
Gene-Disease Validity (ClinGen)
craniosynostosis 6 · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.93). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
13 unique Pathogenic / Likely Pathogenic· 96 VUS of 205 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.36LOEUF
pLI 0.934
Z-score 3.09
OE 0.08 (0.030.36)
Highly constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.57Z-score
OE missense 0.57 (0.500.65)
160 obs / 281.3 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.08 (0.030.36)
00.351.4
Missense OE?0.57 (0.500.65)
00.61.4
Synonymous OE?1.32
01.21.6
LoF obs/exp: 1 / 13.0Missense obs/exp: 160 / 281.3Syn Z: -2.81
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveZIC1-related craniosynostosisGOFAD

This gene — mechanism propensity

DN
0.5870th %ile
GOF
0.2597th %ile
LOF
0.88top 5%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 54% of P/LP variants are LoF · LOEUF 0.36
GOF1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFHeterozygous gain of function mutations in the ZIC1 gene have been described with syndromic craniosynostosis, variable cerebral or cerebellar abnormalities and mild to moderate developmental delay.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 30391508

ClinVar Variant Classifications

205 submitted variants in ClinVar

Classification Summary

Pathogenic6
Likely Pathogenic7
VUS96
Likely Benign77
Benign15
Conflicting2
6
Pathogenic
7
Likely Pathogenic
96
VUS
77
Likely Benign
15
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
2
0
0
6
Likely Pathogenic
3
4
0
0
7
VUS
4
88
3
1
96
Likely Benign
0
8
12
57
77
Benign
0
5
4
6
15
Conflicting
2
Total111071964203

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

18 pathogenic / likely-pathogenic (of 22) ClinVar copy-number / structural variants overlap ZIC1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ZIC1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →